Company: NDRA
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001213900-25-110887
Chunk: 326

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part II, Item 5
Chunk 326
---
-01
    2025-09-30

    0001681682
    
      ndra:SharesIssuableUponConversionOfSeriesAConvertiblePreferredStockMember

    2024-01-01
    2024-12-31

    0001681682
    
      ndra:RestrictedStockUnitsMember

    2025-01-01
    2025-09-30

    0001681682
    
      ndra:RestrictedStockUnitsMember

    2024-01-01
    2024-12-31

    0001681682
    
      ndra:PropertyLeaseholdAndCapitalizedSoftwareMember

    2025-09-30

    0001681682
    
      ndra:PropertyLeaseholdAndCapitalizedSoftwareMember

    2024-12-31

    0001681682
    
      ndra:TAEUSDevelopmentAndTestingMember

    2025-09-30

    0001681682
    
      ndra:TAEUSDevelopmentAndTestingMember

    2024-12-31

    0001681682
    
      ndra:TDBankLoanMember

    2025-04-27

    0001681682
    
      us-gaap:PreferredStockMember

    2025-09-30

    0001681682
    
      ndra:February2024ATMAgreementMember

    2025-01-01
    2025-09-30

    0001681682
    
      us-gaap:RestrictedStockUnitsRSUMember

    2025-06-11
    2025-06-11

    0001681682
    
      us-gaap:RestrictedStockUnitsRSUMember

    2025-06-11

    0001681682
    
      us-gaap:RestrictedStockUnitsRSUMember

    2025-07-01
    2025-09-30

    0001681682
    
      us-gaap:RestrictedStockUnitsRSUMember

    2025-01-01
    2025-09-30

    0001681682

    2023-11-30
    2023-11-30

    0001681682

    2023-11-30

    000